A phase I/II study of nivolumab, paclitaxel, and ramucirumab as second-line in advanced gastric cancer. This is an ASCO Meeting Abstract from the 2020 Gastrointestinal Cancers Symposium. This abstract ...

Chemotherapy is the primary treatment for non-Hodgkin lymphoma, though people may also receive it with immunotherapy. Chemotherapy remains the first-line treatment for non-Hodgkin lymphoma (NHL), a ...

Leveraging Implementation Science to Optimize Strategies for Cancer Control in Mexico and Latin America We enrolled 55 patients with low grade lymphoma. Median age was 58 (range 28-82), 35 (64%) were ...

Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a ...

Reviewed by Chaitra Ujjani, MD, Associate Professor, Division of Medical Oncology, Seattle Cancer Care Alliance, Seattle, Washington Patients with follicular lymphoma (FL) who experience progression ...

Primary thyroid lymphoma (PTL) is an uncommon thyroid malignancy, representing approximately 1–5% of thyroid cancers and 2.5–7% of extranodal lymphomas. Predominantly of B‐cell origin, PTL most ...

Epcoritamab addition to R2 significantly improves progression-free survival and overall response rates in relapsed follicular ...

A cancer grade measures how quickly a cancer is predicted to progress. Doctors typically divide follicular lymphoma into grades 1 to 3 depending on how the cancer cells look under a microscope. The ...

In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction ...

Reduced doses of radiation were shown to be effective for some patients with indolent orbital B-cell lymphoma, researchers said. Ultralow-dose radiation therapy is an effective treatment strategy for ...